Search results
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 3 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 17 hours agoAt the end of the trading day, the stock’s price was $154.84, reflecting an intraday gain of 6.54% or $9.5. The 52-week high for the MRNA share is $170.47 ...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 10 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 8 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 5 hours agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 9 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 10 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoSales are expected to accelerate in a big way in the third quarter, with a projected $1.5 billion,...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...